Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Briacell Therapeutics Corp. T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (TSX:BCT)

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+(TM) and Bria-PROS+(TM) Clinical Candidates for Breast and Prostate Cancer

GlobeNewswire 8 days ago

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

GlobeNewswire 9 days ago

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

GlobeNewswire March 7, 2024

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference

GlobeNewswire March 6, 2024

BriaCell Provides Update on Alleged Illegal Trading of Public Securities

GlobeNewswire February 27, 2024

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case

GlobeNewswire February 7, 2024

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

GlobeNewswire February 6, 2024

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewswire January 30, 2024

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with "Eye-Bulging" Metastatic Breast Cancer

GlobeNewswire January 4, 2024

Bullboard Posts (TSX:BCT)

RE:A lot of good news just out in a short period of time

I think the book runner for the next financing want it down  just too bad for current shareholders
loopsbutterfly - February 29, 2024

A lot of good news just out in a short period of time

I am very upset about the languising share price. It should trade far much higher with all the positive developments. very strange.... ...
loopsbutterfly - January 5, 2024

RE:RE:Running out of cash?

Looks like someone already has. it has been going up the last few trading days with big sp moves. it could be 15 to 20 in a flash...
Unicorn9000 - December 30, 2023

RE:Running out of cash?

If todays news is that good, someone will come knocking. GLTA
MrDales62 - December 20, 2023

Running out of cash?

No matter how promising their results are, aren't they going to run out of cash soon? They will need to find new funds I think...
AnAmateur - December 15, 2023

Big Pharma

Might partner with them and this will skyrocket in no time. good trades today
Unicorn9000 - November 24, 2023